Green Biologics is a renewable chemicals company focused on developing and delivering green alternatives for everyday products. Its core products are renewable n-butanol and acetone. The Company's technology platform is built on biology and chemistry with core expertise in Clostridium microbial fermentation. It is used to develop a robust product pipeline, extending the range of green chemicals and applying downstream synthetic chemistry to generate chemical derivatives used in a wide variety of everyday products, such as paints, coatings, inks, adhesives, textiles, cosmetics, food ingredients, household and industrial cleaners, shampoos and personal care products, fragrances, synthetic rubber, etc.
Type
Private
HQ
Milton, GB
Founded
2003
Size (employees)
79 (est)+2%
Green Biologics was founded in 2003 and is headquartered in Milton, GB
Report incorrect company information

Key People/Management at Green Biologics

Sean Sutcliffe

Sean Sutcliffe

CEO
Steve Breach

Steve Breach

CFO
Tim Davies

Tim Davies

Chief Technology Officer
Patrick Simms

Patrick Simms

Global Vice President Process Development and Scale Up
David Anderson

David Anderson

Global Vice President of Marketing
Timothy Staub

Timothy Staub

Global Vice President Business Development
Show more

Green Biologics Office Locations

Green Biologics has offices in Milton, Columbus and Ashland
Milton, GB (HQ)
Park House Park Dr
Milton, GB
Park Dr
Ashland, US
10338 Stony Run Ln
Columbus, US
1130 Gahanna Pkwy
Show all (4)
Report incorrect company information

Green Biologics Financials and Metrics

Summary Metrics

Founding Date

2003

Total Funding

$84.2 m

Latest funding size

$42 m

Time since last funding

3 years ago

Investors

Green Biologics's latest funding round in January 2015 was reported to be $42 m. In total, Green Biologics has raised $84.2 m

Green Biologics Financials

Green Biologics's revenue was reported to be £6.64 m in FY, 2016
GBP

Revenue (FY, 2016)

6.6 m

Gross profit (FY, 2016)

(3.8 m)

Gross profit margin (FY, 2016), %

(56.9%)

Net income (FY, 2016)

(13.6 m)

EBITDA (FY, 2016)

(7.8 m)

EBIT (FY, 2016)

(14.2 m)

Cash (31-Dec-2016)

2 m
GBPFY, 2007FY, 2014FY, 2015FY, 2016

Revenue

39.1 k1.6 m30 m6.6 m

Revenue growth, %

1829%

Cost of goods sold

22.4 k1.4 m28.5 m10.4 m

Gross profit

16.7 k140.7 k1.6 m(3.8 m)
GBPFY, 2006FY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Cash

109.5 k572.4 k147.1 k784.2 k2.5 m1 m1.2 m10.2 m49.4 m37.6 m2 m

Accounts Receivable

221.6 k235.9 k367.5 k444.8 k475.9 k552 k879.5 k435 k97 k

Inventories

1.1 m979.5 k1 m

Current Assets

139.2 k655.5 k368.6 k1 m2.8 m1.5 m1.7 m10.7 m52.4 m40.5 m4.4 m
GBPFY, 2007FY, 2014FY, 2015FY, 2016

Net Income

(589.5 k)(7.4 m)(13.6 m)(13.6 m)

Cash From Operating Activities

(5.2 m)(2.8 m)(9.9 m)

Cash From Financing Activities

55.1 m(2.4 k)17.5 m

Net Change in Cash

35.7 m(19.8 m)(25.6 m)
GBPY, 2016

Revenue/Employee

103.3 k

Financial Leverage

2.4 x
Show all financial metrics
Report incorrect company information